Formulation and Evaluation of Ion-Responsive in Situ Gel for Ocular Delivery of Lornoxicam: In Vitro and In Vivo Studies
DOI:
https://doi.org/10.31351/vol35iss2pp145-154Keywords:
Lornoxicam, Crospovidone, Ion, Ocular In-situ gel, Gullan gumAbstract
Lornoxicam (LOX) is a potent nonsteroidal anti-inflammatory drug (NSAID) oxicam class; that can be used into treat ocular inflammation; when applied locally to the eye, reducing systemic side effects. However, a major challenge is its rapid lacrimal clearance. An ion-sensitive in-situ gel for lornoxicam (LOX) was developed using gellan gum, a polymer that gel in response to calcium ions present in physiological fluids. This method allows for the local and continuous release of medication, improving therapeutic efficacy. The aim of this study was to formulate and evaluate the efficacy of lornoxicam-loaded in-situ ocular gels Methods A surface solid dispersion of lornoxicam and Crospovidone was prepared and incorporated into the gellan gum-based in-situ gel. Different concentrations of gellan gum were tested changed to create various of formulations, and their impact on viscosity and gelation capacity was assessed. Results: In vitro release experiments; showed that the optimized formulation (F8), containing 0.1% (w/v) lornoxicam and 1% (w/v) gellan gum, released 91.7% of the medication within the first 30 minutes and continued to release over six hours. In an animal model using Rattus norvegicus Domestica, the formulation demonstrated significant therapeutic efficacy in reducing ocular irritation within 72 hours in vivo. Conclusion: The lornoxicam ocular in-situ gel appears to be a promising dosage form that enhances medication retention, reduces drainage, and provides therapeutic benefi
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Alkhiro AR, Ghareeb MM. Formulation and evaluation of lornoxicam as dissolving microneedle patch. Iraqi J Pharm Sci. 2020;29(1):184–94.
Verma NK, Singh AK, Mall PC, Yadav V. Identification and characterization of lornoxicam (non-steroidal anti-inflammatory drug). Int J Pharm Clin Res. 2019;1(2):01–3.
Younus Alkwak RS, Rajab NA. Lornoxicam-Loaded Cubosomes: - Preparation and In vitro Characterization. Iraqi J Pharm Sci. 2022;31(1):144–53.
Ahmed S, Amin MM, Sayed S. Ocular Drug Delivery: A Comprehensive Review. AAPS Pharm SciTech [Internet]. 2023;24(2). Available from: https://doi.org/10.1208/s12249-023-02516-9
Padmasri B, Nagaraju R, Prasanth D. A comprehensive review on in situ gels. Int J Appl Pharm. 2020;12(6):24–33.
Wang Y, Wang C. Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye. Vol. 14, Pharmaceutics. 2022.
Kurniawan Syah IS, Rusdiana T, Sopyan I, Desy Arya IF, Wahab HA, Nurzanah D. Comparative Study of In Situ Gel Formulation Based on the Physio-Chemical Aspect: Systematic Review. Gels. 2023;9(8):1–12.
Cassano R, Di Gioia ML, Trombino S. Gel-based materials for ophthalmic drug delivery. Gels. 2021;7(3).
Gilani SJ, Bin Jumah MN, Zafar A, Imam SS, Yasir M, Khalid M, et al. Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity. Gels. 2022;8(5).
Tatykhanova G, Aseyev V, Vamvakaki M, Khutoryanskiy V, Kudaibergenov S. Ophthalmic drug delivery system based on the complex of gellan and ofloxacin. Chem Bull Kazakh Natl Univ. 2022;(2):4–12.
Abduljabbar HH, Abd Alhammid SN. Enhancement of the Solubility and the Dissolution Rate of Tamoxifen Citrate Solid Dispersion Using Soluplus by Solvent Evaporation Technique. Asian J Pharm Clin Res. 2019;12(1):216.
Chowhan A, Giri TK. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route. Int J Biol Macromol [Internet]. 2020; 150:559–72. Available from: https://doi.org /10.1016/ j. ijbiomac.2020.02.097
Aboumanei MH, Mahmoud AF. Development of Tamoxifen in Situ Gel Nano emulsion for Ocular Delivery in Photoreceptor Degeneration Disorder: In Vitro Characterization, 131I-Radiolabeling, and In Vivo Biodistribution Studies. J Pharm Innova. 2023;18(2):369–80. Available from: https://doi.org/10.1007/s12247-022-09638-w
He Y, Majid K, Maqbool M, Hussain T, Mehmood A, Ullah I, et al. Formulation and characterization of lornoxicam-loaded cellulosic- micro sponge gel for possible applications in arthritis. Saudi Pharm J [Internet]. 2020;28(8):994–1003. Available from: https://doi.org/10.1016/j.jsps.2020.06.021
Aziz HA, J. Al-Akkam E. Preparation and Evaluation of Telmisartan Solid Dispersion as Sublingual Tablets. J Fac Med Baghdad. 2024;65(4).
Jassim BM, Al-Khedairy EBH. Formulation and in vitro /in vivo Evaluation of Silymarin Solid Dispersion-Based Topical Gel for Wound Healing. Iraqi J Pharm Sci. 2023; 32:42–53.
Xu H, Liu Y, Jin L, Chen X, Chen X, Wang Q, et al. Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate in Situ Gel for Ocular Delivery. Pharmaceuticals. 2023;16(1):1–20.
Lin Q, Lim JYC, Xue K, Su X, Loh XJ. Polymeric hydrogels as a vitreous replacement strategy in the eye. Biomaterials 2021; 268:120547. https://doi.org/10.1016/j.biomaterials.2020.120547
Jassim ZE, Mohammed MF, Sadeq ZA. Formulation and evaluation of fast dissolving film of lornoxicam. Asian J Pharm Clin Res. 2018;11(9):217–23.
Budai L, Budai M, Feline Pápay ZE, Vilimi Z, Antal I. Rheological Considerations of Pharmaceutical Formulations: Focus on Viscoelasticity. Gels. 2023;9(6).
Bao Q, Jog R, Shen J, Newman B, Wang Y, Choi S, et al. Physicochemical attributes and dissolution testing of ophthalmic ointments. Int J Pharm.
Dawood, B. Y., & Kassab, H. J. (2019). Preparation and in vitro evaluation of naproxen as a pH-sensitive ocular in-situ gel. International Journal of Applied Pharmaceutics, 11(2), 37-44.
Al-Juboori ZA, Mahdi ZH, Alhamdany AT. Formulation and evaluation of ocular in-situ gelling system containing ciprofloxacin and naproxen sodium. Res J Pharm Technol. 2021;14(1):91–5.
Ibrahim AG, Thomas LM. Formulation and Evaluation of Bilastine Thermosensitive Mucoadhesive Ophthalmic in situ Gel. Al-Rafidain J Med Sci. 2024;7(1):1–7.
Dawood BY, Kassab HJ. Preparation and in vitro evaluation of naproxen as a ph. sensitive ocular insitu gel. Int J Appl Pharm. 2019;11(2):37–44.
Tawfeek HM, Abdellatif AAH, Abdel-Aleem JA, Hassan YA, Fathalla D. Transfersomal gel nanocarriers for enhancement the permeation of lornoxicam. J Drug Deliv Sci Technol. 2020;56(January).
Zwick LS, Patrick DJ, Knupp LC, Ramos MF. Ketamine/Xylazine Anesthesia–Related Corneal Lesions in Rats with Surgically Implanted Venous Catheters Utilized in Nonclinical Intravenous Studies. Toxicol Pathol. 2021;49(3):598–601.
Anumolu PD, Sunitha G, Bindu SH, Satheshbabu PR, Subrahmanyam CVS. Development and validation of discriminating and biorelevant dissolution test for lornoxicam tablets. Indian J Pharm Sci. 2015;77(3):312–20.
Sheth TS, Acharya F. Optimizing similarity factor of in vitro drug release profile for development of early-stage formulation of drug using linear regression model. J Math Ind 2021;11(1). http://dx.doi.org/10.1186/s13362-021-00104-9
Fatima K, Bukhari NI, Latif S, Afzal H, Shamim R, Abbas N. Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer. Drug Dev Ind Pharm. 2021;47(3):498–508 https://doi.org/10.1080/03639045.2021.1892744
Ali FM, Al-Shohani AD. Preparation and Evaluation of in situ Ophthalmic Gel with a Dual Triggered Mechanism for the Delivery of Gatifloxacin and Betamethasone. Al-Rafidain J Med Sci. 2024;6(2):56–63.
J. Neamah M, J. Al- Akkam E. Characterization and Animal Skin Irritations Investigation of Vemurafenib Microemulsion-Based Hydrogel Using Oily Ionic Liquid. Iraqi J Vet Med. 2024;48(1):81–92.
Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Sreeharsha N, Morsy MA, et al. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections. PLoS One. 2021;16(3 March):1–18. http://dx.doi.org/10.1371/journal.pone.0248857.
Meka AK, Pola S, Tupally KR, Abbaraju PL. Development, evaluation and characterization of surface solid dispersion for solubility and dissolution enhancement of Irbesartan. Int J Drug Dev Res 2012;4(1):263–73. Available from: http://dx.doi. org/10.1016/ j.jopr. 2013 .06 .012
Sunitha R, Venugopal K, Satyanarayana S V. Design, Development, and Evaluation of Controlled Release Tablets of Nateglinide Solid Dispersions. Asian J Pharm. 2021;15(1):115–23.
Downloads
Published
License
Copyright (c) 2026 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
